Navigation Links
Marken Appoints New Directors To Board
Date:3/5/2013

RESEARCH TRIANGLE PARK, N.C., March 5, 2013 /PRNewswire/ -- Marken today announced that it has appointed two independent directors to its Board as a result of Marken's recent restructuring completed on December 21, 2012.  The appointment of Timothy C. Tyson and Michael O'Donnell is the next step in Marken's strategy to focus on serving the global life sciences industry.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO)

Tim Tyson is a veteran leader in the global pharmaceutical market place.  He currently serves as Chairman of the Board of Aptuit LLC, a global pharmaceutical services company based in the US.  He was CEO and President of Valeant Pharmaceuticals Inc. from 2003-2008.  Prior to that, Mr. Tyson held various leadership roles including as President, Global Manufacturing & Supply at GlaxoSmithKline (GSK).  During his 14 years at GSK, he led the Glaxo Dermatology and Cerenex Divisions, the US Marketing Division, and the US Sales Divisions where he launched 32 products, eight of which exceeded $1billion in global sales.  Mr. Tyson is an engineering graduate of the US Military Academy at West Point, and holds a masters degree in public administration from Jackson State University. He has held key positions on the PhRMA Board and the International Society of Professional Engineers (ISPE).

Michael O'Donnell currently serves as Chairman of Verna, a company specializing in infectious control products, and as non-executive Director of Helical Bar plc. a property development firm.  He has served as an independent Director on the Boards of seven companies since 2008 and also acted as a consultant to one of Marken's clients.  Prior to 2008, Mr. O'Donnell was a Managing Director of LGV Capital, a private equity firm, where he worked for more than a decade. He started his career at Morgan Grenfell where he worked for five years after graduating from University College, Dublin with a Bachelor of Commerce degree. 

"We are delighted to welcome Tim and Michael to Marken's Board of Directors," said Wes Wheeler , Marken's Chief Executive Officer.  "These two independent Directors will certainly provide us with an appropriate balance of deep industry and financial experience.  They also bring excellent contacts from the pharmaceutical industry and the UK financial markets, respectively, which will allow us to continue our expansion in the life sciences supply chain market." 

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
2. Marken Opens Branch Office In Seoul, South Korea
3. Marken Announces Global Advisory Board
4. Marken Launches New Global Regulatory Consultation Services
5. Marken Enhances Branch Operations
6. Marken Expands Regulatory And Technical Excellence In Logistics
7. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
8. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
9. Nephros Appoints John C. Houghton as President and Chief Executive Officer
10. Elsevier Appoints New President of Elsevier CPM Resource Center
11. GenWay Biotech Appoints New Vice President of Custom/OEM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... PLAD, Inc. (OTC Pink: PLAD) is pleased to announce ... company targets, are adding key personnel to their national ... United States Patent and Trademark Office for the characters ... of PLAD, Inc.  In January, PLAD established their presence ... with two new customers, Cumberland Goodwill EMS and Meadville ...
(Date:2/11/2016)... 2016  M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , ... an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the ...
Breaking Medicine Technology:
(Date:2/11/2016)... City, FL (PRWEB) , ... February 11, 2016 ... ... announced the commencement of a master charity program created to assist the people ... 60 days, working closely with nonprofit organizations and community leaders. Their hope is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Duterte Insurance Group, serving ... introduces a new charity campaign to raise funds for Ronald McDonald House Charities. ... https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is an internationally renowned nonprofit ...
(Date:2/11/2016)... ... ... Be Well Medical Group (Be Well) is pleased to announce ... South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a concierge ... of their homes, offices or at the practices’ local office. It is also one ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling for American ... and wellness best practices in the past couple of decades, and food manufacturers ... Heart Month, which acts as an exceptional opportunity to revise food labels and ...
(Date:2/10/2016)... ... 10, 2016 , ... President Obama’s budget proposal yesterday enables ... medical services via telehealth, estimated to generate more than $160 million in savings ... many years. Although there is more to be done, this represents an ...
Breaking Medicine News(10 mins):